Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression. | Front Immunol | 2023 | 37256148 | PubTator, text mining | PubMed |
| Prediction of risk and overall survival of pancreatic cancer from blood soluble immune checkpoint-related proteins. | Front Immunol | 2023 | 37256126 | PubTator, text mining | PubMed |
| Combined analysis of single-cell and bulk RNA sequencing reveals the expression patterns of circadian rhythm disruption in the immune microenvironment of Alzheimer's disease. | Front Immunol | 2023 | 37251379 | PubTator, text mining | PubMed |
| Redox Signaling Modulates Activity of Immune Checkpoint Inhibitors in Cancer Patients. | Biomedicines | 2023 | 37238995 | PubTator, text mining | PubMed |
| NEK2 promotes esophageal squamous cell carcinoma cell proliferation, migration and invasion through the Wnt/β-catenin signaling pathway. | Discov Oncol | 2023 | 37233832 | PubTator, text mining | PubMed |
| Adverse Effects of Immune-Checkpoint Inhibitors: A Comprehensive Imaging-Oriented Review. | Curr Oncol | 2023 | 37232813 | PubTator, text mining | PubMed |
| Rapid TCR:Epitope Ranker (RAPTER): a primary human T cell reactivity screening assay pairing epitope and TCR at single cell resolution. | Sci Rep | 2023 | 37231180 | PubTator, text mining | PubMed |
| Molecular events in the jaw vascular unit: A traditional review of the mechanisms involved in inflammatory jaw bone diseases. | J Biomed Res | 2023 | 37226540 | PubTator, text mining | PubMed |
| Radiation combined with immune checkpoint inhibitors for unresectable locally advanced non-small cell lung cancer: synergistic mechanisms, current state, challenges, and orientations. | Cell Commun Signal | 2023 | 37221584 | PubTator, text mining | PubMed |
| Extensive cytokine biomarker analysis in serum of Guillain-Barré syndrome patients. | Sci Rep | 2023 | 37221406 | PubTator, text mining | PubMed |
| Predictive plasma biomarkers of long-term increase in hepatic steatosis index after HCV eradication in HIV/HCV-coinfected patients. | Biomed Pharmacother | 2023 | 37216704 | PubTator, text mining | PubMed |
| Extracellular RNA in melanoma: Advances, challenges, and opportunities. | Front Cell Dev Biol | 2023 | 37215082 | PubTator, text mining | PubMed |
| Mitochondrial metabolic reprogramming-mediated immunogenic cell death reveals immune and prognostic features of clear cell renal cell carcinoma. | Front Oncol | 2023 | 37213288 | PubTator, text mining | PubMed |
| Cytolytic CD8+ T cells infiltrate germinal centers to limit ongoing HIV replication in spontaneous controller lymph nodes. | Sci Immunol | 2023 | 37205767 | PubTator, text mining | PubMed |
| Regulatory T cells in peripheral tissue tolerance and diseases. | Front Immunol | 2023 | 37197653 | PubTator, text mining | PubMed |
| An overview of extrahepatic cholangiocarcinoma: from here to where? | Front Oncol | 2023 | 37197436 | PubTator, text mining | PubMed |
| Single-Cell Transcriptome Atlas of Newcastle Disease Virus in Chickens Both In Vitro and In Vivo. | Microbiol Spectr | 2023 | 37191506 | PubTator, text mining | PubMed |
| TIGD1 Function as a Potential Cuproptosis Regulator Following a Novel Cuproptosis-Related Gene Risk Signature in Colorectal Cancer. | Cancers (Basel) | 2023 | 37190215 | PubTator, text mining | PubMed |
| Inflammatory Networks in Renal Cell Carcinoma. | Cancers (Basel) | 2023 | 37190141 | PubTator, text mining | PubMed |
| Identification of the Prognostic Biomarkers CBX6 and CBX7 in Bladder Cancer. | Diagnostics (Basel) | 2023 | 37189494 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=27